Search results
Danone steps up health focus to boost growth
Reuters· 52 minutes ago, opens new tab will step up its focus on health and medical nutrition as it seeks to grow sales and boost cash generation from 2025 to 2028, the company...
Danone announces plan to reverse performance which has lagged rivals
Market Watch· 3 hours agoDanone aims to increase sales and earnings through 2028, aided by an expansion of its footprint and...
Danone Targets Sales, Profit Growth in the Next Four Years
The Wall Street Journal· 3 hours agoDanone said it would sharpen its focus on health and nutrition, aiming to increase sales and...
Danone Targets Health, Nutrition as Food Industry Braces for Ozempic Era
The Wall Street Journal· 3 hours agoDanone plans to double down on health and nutrition in the coming years as food companies seek to...
Danone, like Swiss competitor Nestle, is doubling down on foods for an aging population
Fortune· 3 days agoThe medical nutrition unit will be a big part of the next stage of Danone’s recovery effort, after Chief Executive Officer Antoine de Saint-Affrique began to revive growth ...
Danone Bets Aging Populace Will Drive Medical Nutrition Demand
Bloomberg· 3 days agoDanone, the French yogurt maker in the midst of a turnaround, is stepping up investment in...
Danone aiming to scale up precision fermentation with aid of partners
Just Food via Yahoo Finance· 7 days agoFrench dairy giant Danone is teaming up on a project to invest in precision fermentation. It is...
European shares open higher on tech boost ahead of cenbank decision flurry By Reuters
Investing.com· 2 hours agoTechnology stocks led gains, rising 0.7%, with construction and materials also rising 0.7%. Lifting...
Why should food companies consider becoming B Corp?
Just Food via Yahoo Finance· 2 days agoFurther underlining the significance of B Corp to the food sector is the support the movement is receiving from a number of its largest players, notably...
Gateway - Quartz
Quartz· 2 days agoUnlike many other food executives, Danone CEO Antoine de Saint-Affrique is optimistic about what the the skyrocketing demand for GLP-1 weight loss drugs could mean for the ...
